QuantLogix ← MET scorecard
📅 MET Earnings Preview
MetLife, Inc.
Next report (est.)
11/29/2026
Countdown
81 days
EPS growth YoY
+5.8%
Revenue growth YoY
+10.5%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/06/2026 ±1.7% +3.8% under-priced
05/07/2026 ±2.2% -1.7% over-priced
11/07/2025 ±3.1% +0.2% over-priced
08/07/2025 ±2.2% -2.8% under-priced
05/01/2025 ±2.6% +0.5% over-priced
08/01/2024 ±1.9% -1.4% over-priced
05/02/2024 ±2.0% -2.3% under-priced
11/02/2023 ±2.1% +0.1% over-priced
Across these reports, options implied an average ±2.2% move vs an actual average of 1.6% — the stock stayed inside the implied band 63% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $1.09 $19.2B $779M
Q1 FY2026 $1.74 $19.1B $1.2B
Q4 FY2025 $1.17 $23.8B $816M
Q3 FY2025 $1.22 $17.4B $902M
Analyst posture
Buy / Strong Buy
17
Hold
7
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 67/100 Full scorecard →
Get alerted before every MET report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MET before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

MetLife, Inc. (MET) reports in 81 days, with the next report estimated for 11/29/2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 1.6% on average — the market has been roughly fair on MET's earnings risk. Fundamentals into the print: EPS up 5.8% year-over-year, revenue up 10.5%. QuantLogix's live 5-factor engine currently reads MET as a buy at 67/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →